fusidic acid has been researched along with fosfomycin in 20 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (fosfomycin) | Trials (fosfomycin) | Recent Studies (post-2010) (fosfomycin) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 2,335 | 181 | 1,022 |
| Protein | Taxonomy | fusidic acid (IC50) | fosfomycin (IC50) |
|---|---|---|---|
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Escherichia coli K-12 | 3.5795 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Desplaces, N; Dzeing-Ella, A; Kitzis, MD; Mamoudy, P; Zeller, V; Ziza, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Briedigkeit, H; Halle, E | 1 |
| Simon, M; Simon, VC | 1 |
| Breyer, S; Francesconi, M; Georgopoulos, A; Graninger, W; Leitha, T; Lenz, K | 1 |
| Guenthner, SH; Wenzel, RP | 1 |
| Caillon, J; Drugeon, HB; Juvin, ME | 1 |
| Endtz, HP; Gyssens, IC; Löwenberg, B; Silbermann, MH; Wielenga, JJ | 1 |
| Andrieu, P; Archambaud, M; Brown, L; Cougot, P; Decun, JF; Georges, B; Mazerolles, M; Suc, C; Virenque, C | 1 |
| Gidoh, M | 1 |
| Apisarnthanarak, A; Mundy, LM | 1 |
| Falagas, ME; Kopterides, P | 1 |
| Falagas, ME; Grammatikos, AP; Michalopoulos, A | 1 |
| Cai, Y; Liang, BB; Lin, DF; Song, XJ; Wang, R; Yu, XH | 1 |
| Champion, EA; Hobbs, MM; Miller, MB; Muhlebach, MS; Popowitch, EB; Saiman, L | 1 |
| Boyanova, L | 1 |
| Cong, Y; Fan, B; Guan, J; Wang, X | 1 |
| Argemi, X; Baldeyrou, M; Christmann, D; Cianférani, S; Douiri, N; Hansmann, Y; Keller, D; Lefebvre, N; Meghit, K; Meyer, N; Prévost, G; Riegel, P; Ronde Oustau, C; Strub, JM | 1 |
| Aktas, G; Derbentli, S | 1 |
3 review(s) available for fusidic acid and fosfomycin
| Article | Year |
|---|---|
[The control leprous peripheral neuropathy and chemotherapy].
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Leprostatic Agents; Leprosy; Minocycline; Peripheral Nervous System Diseases; Protein Synthesis Inhibitors; Rats; Roxithromycin | 1999 |
Old antibiotics for infections in critically ill patients.
Topics: Anti-Bacterial Agents; Chloramphenicol; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Fosfomycin; Fusidic Acid; Gentamicins; Humans; Polymyxins | 2007 |
Potential of old-generation antibiotics to address current need for new antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Colistin; Drug Resistance, Bacterial; Drug Utilization; Fosfomycin; Fusidic Acid; Humans; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
17 other study(ies) available for fusidic acid and fosfomycin
| Article | Year |
|---|---|
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Clindamycin; Cohort Studies; Drug Interactions; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Joint Diseases; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Recommendations for the indication-justified use of antibiotics. 3: macrolides, lincosamide, glycopeptide antibiotics, fusidic acid, fosfomycin].
Topics: Anti-Bacterial Agents; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Infections; Lincosamides; Macrolides; Rifampin | 1991 |
Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Topics: Catheters, Indwelling; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1990 |
Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Topics: Cefamandole; Clindamycin; Fosfomycin; Fusidic Acid; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1985 |
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Floxacillin; Fosfomycin; Fusidic Acid; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Vancomycin | 1984 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin].
Topics: Adolescent; Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Meningitis, Bacterial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
[Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fosfomycin; Fusidic Acid; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Vancomycin | 1997 |
Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 2007 |
In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; China; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Guidelines as Topic; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2010 |
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bronchoscopy; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; DNA, Bacterial; Exotoxins; Female; Fosfomycin; Fusidic Acid; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Molecular Typing; Mupirocin; Oxazolidinones; Penicillin-Binding Proteins; Pharynx; Pneumonia, Staphylococcal; Sequence Analysis, DNA; Sputum; Staphylococcal Infections; Staphylococcal Protein A; Tetracycline; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2014 |
Susceptibility of anaerobes to fusidic acid and fosfomycin.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Child; Female; Fosfomycin; Fusidic Acid; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2015 |
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Fusidic Acid; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulbactam; Thienamycins; Tigecycline | 2016 |
VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Aminoglycosides; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Follow-Up Studies; Fosfomycin; Fusidic Acid; Humans; Male; Metalloproteases; Methicillin; Middle Aged; Phosphonoacetic Acid; Prospective Studies; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Virulence Factors | 2017 |
In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections | 2017 |